BMC Medicine is a prestigious, peer-reviewed journal published by BMC, specializing in the rapidly evolving field of medicine. Launched in 2003, this journal has consistently operated under an Open Access model, ensuring that groundbreaking research is freely accessible to the global community. With an impressive impact factor, BMC Medicine holds a distinguished Q1 ranking in the field of Medicine (miscellaneous) and ranks #29 out of 636 in General Medicine according to Scopus, placing it in the top 95th percentile of its category. This journal is dedicated to disseminating high-quality research that advances the understanding and practice of medicine, with a comprehensive focus that includes clinical research, public health, and health policy. As part of its commitment to fostering innovation and collaboration in healthcare, BMC Medicine invites researchers, professionals, and students to contribute to this vital platform that addresses the most pressing medical challenges of our time.

BIOMEDICAL RESEARCH-TOKYO is an esteemed interdisciplinary journal published by BIOMEDICAL RESEARCH PRESS LTD, dedicated to disseminating pioneering research and advancements in the fields of biochemistry, genetics, and medicine. Since its inception in 1980, the journal has established itself as a reputable source of knowledge, contributing significantly to the global scientific community with its strong emphasis on innovative findings and methodologies. With a consistent presence in the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it continues to attract a diverse range of research articles. While the journal does not operate as an open access platform, it remains an essential resource for researchers, professionals, and students seeking to further their understanding of biomedical sciences. Located in Sapporo, Japan, this journal fosters collaboration and knowledge sharing among the international biomedical research community, engaging readers through its compelling studies that span from 1980 to 2024.

CienciaUat is a distinguished academic journal published by the Universidad Autónoma de Tamaulipas, dedicated to fostering innovative research across various scientific disciplines. With an ISSN of 2007-7521 and an E-ISSN of 2007-7858, this journal serves as a platform for the dissemination of high-quality research findings that contribute to the advancement of science and technology within both local and international contexts. The journal aims to promote scholarly communication among researchers, professionals, and students, emphasizing the importance of empirical evidence and interdisciplinary approaches. Though specific metrics like H-Index and Scopus rankings are currently not provided, CienciaUat is committed to maintaining rigorous peer-review standards. The journal’s open-access model facilitates wide accessibility, ensuring that pivotal research reaches a global audience. The editorial team encourages submissions that adhere to the highest academic standards, reflecting innovation and relevance in today’s scientific landscape.

PLOS BIOLOGY, published by PUBLIC LIBRARY SCIENCE, is a leading open-access journal that has been at the forefront of biological research since its inception in 2003. This high-impact journal (with an impressive Scopus ranking placing it in the top 10% across multiple biological disciplines) aims to disseminate groundbreaking research findings in a variety of fields, including Biochemistry, Genetics, Molecular Biology, Immunology, Microbiology, and Neuroscience. With a commitment to open-access principles, PLOS BIOLOGY ensures that its content is freely available to a global audience, fostering collaboration and innovation among researchers, professionals, and students worldwide. Its Q1 quartile status in 2023 highlights the journal's prestigious standing within the academic community, making it an essential resource for those seeking to stay updated with the latest advancements in biological sciences. The journal's scope extends from 2003 to 2024, reflecting its sustained relevance and impact in driving forward biological discoveries.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

STAR Protocols, published by Elsevier, is an esteemed open access journal that has been at the forefront of providing innovative experimental protocols since its inception in 2020. With a distinct focus on a range of scientific disciplines including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, this journal serves as a vital resource for researchers, professionals, and students alike. The journal holds a commendable status, reflected by its Q1 and Q2 rankings across various relevant categories, ensuring the dissemination of high-impact research methods and findings. With its open access format, STAR Protocols encourages a broad readership and facilitates the sharing of pivotal knowledge in the scientific community, driving forward the culture of transparency and collaboration in research. Positioned in the vibrant academic landscape of the United States, it steadily contributes to the evolution of experimental methodologies, fostering innovation across disciplines.

Biochemia Medica is a premier open-access journal that has been at the forefront of advancing knowledge in the fields of medical biochemistry and laboratory medicine since its inception in 2006. Published by the Croatian Society of Medical Biochemistry & Laboratory Medicine, this journal serves a vital role in disseminating high-quality research findings and reviews that contribute to the understanding of biochemical processes in health and disease. With an impressive performance in the Scopus ranking, it holds a Q2 quartile category in both medical biochemistry and clinical biochemistry for 2023, reflecting its commitment to scholarly excellence and relevance in the field. As an open-access journal, Biochemia Medica ensures that research is freely accessible, fostering collaboration and innovation among researchers, healthcare professionals, and students globally. Positioned within a rapidly evolving scientific landscape, this journal is dedicated to bridging the gap between laboratory research and clinical application, making it an indispensable resource for anyone interested in the intersections of biochemistry and medicine.

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

Libyan Journal of Medicine, published by TAYLOR & FRANCIS LTD, is a prominent open-access journal dedicated to advancing the field of medicine, particularly within the context of Libyan and broader Mediterranean health challenges. Since its inception in 2006, the journal has facilitated the dissemination of vital research findings, offering unrestricted access to its rich repository of knowledge, which enhances visibility and accessibility for researchers, clinicians, and students alike. Ranking in the Q3 category within the Medicine (miscellaneous) sector for 2023, and positioned at Rank #147 out of 636 in the general medicine category on Scopus, it reflects a notable recognition for its contributions to medical research. The journal aims not only to publish high-quality articles that span a variety of medical disciplines but also to foster collaboration and communication among the international medical community. As it converges its focus from 2009 to 2024, the Libyan Journal of Medicine serves as an invaluable resource for cutting-edge research and innovative medical practices.

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.